Viking Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Go back to Viking Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Viking Therapeutics (VKTX) Misses Q1 EPS by 8c

April 23, 2025 4:12 PM EDT

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($0.41), $0.08 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

... More